Your browser doesn't support javascript.
loading
Clinical Outcomes, Immunogenicity, and Safety of BNT162b2 Vaccine in Primary Antibody Deficiency.
Milota, Tomas; Smetanova, Jitka; Skotnicova, Aneta; Rataj, Michal; Lastovicka, Jan; Zelena, Hana; Parackova, Zuzana; Fejtkova, Martina; Kanderova, Veronika; Fronkova, Eva; Rejlova, Katerina; Sediva, Anna; Kalina, Tomas.
  • Milota T; Department of Immunology, Second Faculty of Medicine Charles University and Motol University Hospital, Prague, Czech Republic. Electronic address: tomas.milota@fnmotol.cz.
  • Smetanova J; Department of Immunology, Second Faculty of Medicine Charles University and Motol University Hospital, Prague, Czech Republic.
  • Skotnicova A; Childhood Leukemia Investigation Prague, Second Faculty of Medicine Charles University and Motol University Hospital, Prague, Czech Republic.
  • Rataj M; Department of Immunology, Second Faculty of Medicine Charles University and Motol University Hospital, Prague, Czech Republic.
  • Lastovicka J; Department of Immunology, Second Faculty of Medicine Charles University and Motol University Hospital, Prague, Czech Republic.
  • Zelena H; Department of Virology, Public Health Institute, Ostrava, Czech Republic.
  • Parackova Z; Department of Immunology, Second Faculty of Medicine Charles University and Motol University Hospital, Prague, Czech Republic.
  • Fejtkova M; Childhood Leukemia Investigation Prague, Second Faculty of Medicine Charles University and Motol University Hospital, Prague, Czech Republic.
  • Kanderova V; Childhood Leukemia Investigation Prague, Second Faculty of Medicine Charles University and Motol University Hospital, Prague, Czech Republic.
  • Fronkova E; Childhood Leukemia Investigation Prague, Second Faculty of Medicine Charles University and Motol University Hospital, Prague, Czech Republic.
  • Rejlova K; Childhood Leukemia Investigation Prague, Second Faculty of Medicine Charles University and Motol University Hospital, Prague, Czech Republic.
  • Sediva A; Department of Immunology, Second Faculty of Medicine Charles University and Motol University Hospital, Prague, Czech Republic.
  • Kalina T; Childhood Leukemia Investigation Prague, Second Faculty of Medicine Charles University and Motol University Hospital, Prague, Czech Republic.
J Allergy Clin Immunol Pract ; 11(1): 306-314.e2, 2023 01.
Article en En | MEDLINE | ID: mdl-36379409

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / Inmunodeficiencia Variable Común / Enfermedades de Inmunodeficiencia Primaria / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / Inmunodeficiencia Variable Común / Enfermedades de Inmunodeficiencia Primaria / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article